Sun Pharmaceutical Industries Limited has announced its 34th Annual General Meeting (AGM) to be held on Friday, July 31, 2026, via Video Conferencing. The company also fixed Tuesday, July 7, 2026, as the record date for determining shareholders entitled to a final dividend of ₹5 per equity share for FY 2025-26. The dividend payment, subject to shareholder approval, is expected on or before Friday, August 7, 2026.
34th Annual General Meeting Scheduled
Sun Pharmaceutical Industries Limited will convene its 34th Annual General Meeting (AGM) on Friday, July 31, 2026. The meeting is scheduled to commence at 4:00 p.m. IST and will be conducted through Video Conferencing (VC). Shareholders will receive the notice for the AGM and the Annual Report for the financial year 2025-26 in due course, as per statutory requirements. Shareholders are urged to update their latest contact details with their Depository Participants or the Company’s Registrar and Transfer Agent to ensure timely receipt of all documents and dividend credits.
Record Date and Final Dividend for FY 2025-26
The company has fixed Tuesday, July 7, 2026, as the Record Date for the purpose of determining the eligibility of shareholders to receive the final dividend. The proposed final dividend is ₹5/- (Rupees Five only) per equity share for the financial year 2025-26. This dividend is subject to the approval of the shareholders at the upcoming AGM. The payment of this final dividend is planned to be made on or before Friday, August 7, 2026.
Dividend Tax Deduction at Source (TDS)
Dividend income is subject to deduction of tax at source (TDS) at applicable rates. Shareholders are advised to refer to the TDS guidance and the document submission process detailed on the company’s website, www.sunpharma.com, or via the provided QR code. Any requisite documents for TDS purposes must be submitted by Tuesday, July 7, 2026, to ensure the correct TDS rate is applied.
Source: BSE
